Grown Rogue International (GRUSF) Cash from Operations (2013 - 2026)
Grown Rogue International (GRUSF) recorded quarterly Cash from Operations of 2534524.0 in Q1 2026, up 100.0% quarter-over-quarter from 230723430205.0 in Q4 2025, and up 352.3% on a YoY basis from 560367.34 in Q1 2025.
Grown Rogue International (GRUSF) Cash from Operations (2013 - 2026) Analysis & Trends
Grown Rogue International's Cash from Operations history runs 13 years deep, the most recent figure standing at 2534524.0 for Q1 2026.
- In Q1 2026, Cash from Operations rose 352.3% year-over-year to 2534524.0; the TTM figure through Mar 2026 stood at 230721396777.04 (down 7223113.21% YoY), while the FY2025 annual figure was 3569795.0, up 36.51% from the prior year.
- Cash from Operations was 2534524.0 for Q1 2026 at Grown Rogue International, up from 230723430205.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 3586881.17 in Q4 2023 to a low of 230723430205.0 in Q4 2025.
- Historically, Cash from Operations has averaged 25634532317.31 across 4 years, with a median of 1460704.02 in 2024.
- The sharpest annual moves came in 2025 and 2026: Cash from Operations tumbled 15247565.85% in 2025, then surged 352.3% in 2026.
- A 4-year view of Cash from Operations shows it stood at 3586881.17 in 2023, then slumped by 57.81% to 1513191.98 in 2024, then slumped by 15247565.85% to 230723430205.0 in 2025, then jumped by 100.0% to 2534524.0 in 2026.
- The last three Cash from Operations figures came in at 2534524.0 (Q1 2026), 230723430205.0 (Q4 2025), and 503483.96 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -40.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 401.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 463.30 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 145.80 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 13.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -165.74 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 89.36 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 125.13 Mn |
| 10 | Grown Rogue International | - | - | 3.96 Mn | 2.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.53 Mn |
| Mar 31, 2026 | 2.53 Mn |
| Dec 31, 2025 | -230.72 Bn |
| Dec 31, 2025 | -230.72 Bn |
| Jun 30, 2025 | 503,483.96 |
| Jun 30, 2025 | 503,483.96 |
| Mar 31, 2025 | -1.00 Mn |
| Mar 31, 2025 | -1.00 Mn |
| Dec 31, 2024 | 1.51 Mn |
| Dec 31, 2024 | 1.51 Mn |
| Sep 30, 2024 | 1.22 Mn |
| Sep 30, 2024 | 1.22 Mn |
| Jun 30, 2024 | 1.46 Mn |
| Jun 30, 2024 | 1.46 Mn |
| Oct 31, 2023 | 3.59 Mn |
| Oct 31, 2023 | 3.59 Mn |
| Jul 31, 2023 | 2.82 Mn |
| Jul 31, 2023 | 2.82 Mn |
| Oct 31, 2021 | 526.78 Bn |
| Oct 31, 2021 | 526.78 Bn |